Grace Therapeutics (GRCE) Q2 2025 Earnings

Jun 23Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.37
-0.21
-0.05
0.11

Details

Expected EPS
-0.2775
Actual EPS
0.11
Surprise EPS
0.39
Surprise Percent
+139.64%

Description

⁨Grace Therapeutics⁩ (⁦GRCE⁩) has reported earnings of ⁦0.11⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts